17-745992-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015721.3(GEMIN4):​c.2051G>A​(p.Arg684Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.157 in 1,613,082 control chromosomes in the GnomAD database, including 23,573 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3920 hom., cov: 32)
Exomes 𝑓: 0.15 ( 19653 hom. )

Consequence

GEMIN4
NM_015721.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.502

Publications

69 publications found
Variant links:
Genes affected
GEMIN4 (HGNC:15717): (gem nuclear organelle associated protein 4) The product of this gene is part of a large complex localized to the cytoplasm, nucleoli, and to discrete nuclear bodies called Gemini bodies (gems). The complex functions in spliceosomal snRNP assembly in the cytoplasm, and regenerates spliceosomes required for pre-mRNA splicing in the nucleus. The encoded protein directly interacts with a DEAD box protein and several spliceosome core proteins. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
GEMIN4 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039718747).
BP6
Variant 17-745992-C-T is Benign according to our data. Variant chr17-745992-C-T is described in ClinVar as Benign. ClinVar VariationId is 1185308.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.319 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GEMIN4NM_015721.3 linkc.2051G>A p.Arg684Gln missense_variant Exon 2 of 2 ENST00000319004.6 NP_056536.2 P57678Q8WUM5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GEMIN4ENST00000319004.6 linkc.2051G>A p.Arg684Gln missense_variant Exon 2 of 2 1 NM_015721.3 ENSP00000321706.5 P57678
GEMIN4ENST00000576778.1 linkc.2018G>A p.Arg673Gln missense_variant Exon 1 of 1 6 ENSP00000459565.1 I3L2C7

Frequencies

GnomAD3 genomes
AF:
0.206
AC:
31356
AN:
151958
Hom.:
3906
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.319
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.267
Gnomad ASJ
AF:
0.104
Gnomad EAS
AF:
0.332
Gnomad SAS
AF:
0.258
Gnomad FIN
AF:
0.124
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.204
GnomAD2 exomes
AF:
0.199
AC:
49475
AN:
248362
AF XY:
0.194
show subpopulations
Gnomad AFR exome
AF:
0.324
Gnomad AMR exome
AF:
0.325
Gnomad ASJ exome
AF:
0.111
Gnomad EAS exome
AF:
0.335
Gnomad FIN exome
AF:
0.128
Gnomad NFE exome
AF:
0.130
Gnomad OTH exome
AF:
0.171
GnomAD4 exome
AF:
0.152
AC:
222368
AN:
1461006
Hom.:
19653
Cov.:
63
AF XY:
0.154
AC XY:
112131
AN XY:
726800
show subpopulations
African (AFR)
AF:
0.319
AC:
10683
AN:
33476
American (AMR)
AF:
0.317
AC:
14150
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
2836
AN:
26134
East Asian (EAS)
AF:
0.265
AC:
10524
AN:
39690
South Asian (SAS)
AF:
0.258
AC:
22268
AN:
86242
European-Finnish (FIN)
AF:
0.127
AC:
6729
AN:
52898
Middle Eastern (MID)
AF:
0.178
AC:
1024
AN:
5758
European-Non Finnish (NFE)
AF:
0.129
AC:
143658
AN:
1111788
Other (OTH)
AF:
0.174
AC:
10496
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
11342
22685
34027
45370
56712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5540
11080
16620
22160
27700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.207
AC:
31415
AN:
152076
Hom.:
3920
Cov.:
32
AF XY:
0.208
AC XY:
15463
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.318
AC:
13202
AN:
41470
American (AMR)
AF:
0.268
AC:
4091
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
362
AN:
3470
East Asian (EAS)
AF:
0.332
AC:
1699
AN:
5122
South Asian (SAS)
AF:
0.259
AC:
1248
AN:
4824
European-Finnish (FIN)
AF:
0.124
AC:
1316
AN:
10594
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.132
AC:
8965
AN:
68004
Other (OTH)
AF:
0.212
AC:
447
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1248
2496
3743
4991
6239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.159
Hom.:
9959
Bravo
AF:
0.220
TwinsUK
AF:
0.128
AC:
475
ALSPAC
AF:
0.121
AC:
468
ESP6500AA
AF:
0.304
AC:
1197
ESP6500EA
AF:
0.126
AC:
1049
ExAC
AF:
0.196
AC:
23660
Asia WGS
AF:
0.342
AC:
1185
AN:
3478
EpiCase
AF:
0.135
EpiControl
AF:
0.139

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 15, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23322153) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.36
DANN
Benign
0.64
DEOGEN2
Benign
0.0089
T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.55
T;T
MetaRNN
Benign
0.0040
T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.0
N;.
PhyloP100
0.50
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.020
N;.
REVEL
Benign
0.011
Sift
Benign
0.58
T;.
Sift4G
Benign
0.58
T;T
Polyphen
0.37
B;.
Vest4
0.027
MPC
0.18
ClinPred
0.0021
T
GERP RS
0.42
Varity_R
0.014
gMVP
0.062
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3744741; hg19: chr17-649232; COSMIC: COSV56745132; COSMIC: COSV56745132; API